Overview

Safety and Tolerability Study of K0706 in Subjects With Parkinson's Disease

Status:
Completed
Trial end date:
2019-05-28
Target enrollment:
Participant gender:
Summary
This is a safety, tolerability and pharmacokinetic study in subjects with Parkinson's disease
Phase:
Phase 1
Details
Lead Sponsor:
Sun Pharma Advanced Research Company Limited